1. Home
  2. Analysis

Hyperphosphataemia and drugs of ingredients of sofosbuvir (a real world drug study)


Summary:

Hyperphosphataemia is reported only by a few people who take drugs with ingredients of sofosbuvir. This phase IV clinical study analyzes 21,826 people who have side effects while taking drugs with ingredients of sofosbuvir from the the FDA. Among them, 1 have Hyperphosphataemia. Find out below who they are, when they have Hyperphosphataemia and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Sofosbuvir, Sovaldi.

On Jun, 18, 2026

21,826 people reported to have side effects when taking drugs with ingredients of sofosbuvir.
Among them, 1 person (0.0%) has Hyperphosphataemia

What is Hyperphosphataemia?

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood) is found to be associated with 431 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperphosphataemia.

Number of reports submitted per year:

Could drugs with ingredients of sofosbuvir cause Hyperphosphataemia?

Time on drugs with ingredients of sofosbuvir when people have Hyperphosphataemia *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hyperphosphataemia when taking drugs with ingredients of sofosbuvir *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Hyperphosphataemia when taking drugs with ingredients of sofosbuvir *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Hepatitis C: 1 person, 100.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Zantac: 1 person, 100.00%
  2. Pred Forte: 1 person, 100.00%
  3. Phoslo: 1 person, 100.00%
  4. Oxycodone: 1 person, 100.00%
  5. Multivitamin: 1 person, 100.00%
  6. Ibrutinib: 1 person, 100.00%
  7. Cosopt: 1 person, 100.00%
  8. Ambien: 1 person, 100.00%

Other side effects people have besides Hyperphosphataemia *:

You may use this to check any potential undetected side effects.

  1. Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 1 person, 100.00%
  2. Parotid Gland Enlargement: 1 person, 100.00%
  3. Memory Loss: 1 person, 100.00%
  4. Hyperkalemia (damage to or disease of the kidney): 1 person, 100.00%
  5. Dehydration (dryness resulting from the removal of water): 1 person, 100.00%
  6. Confusional State: 1 person, 100.00%
  7. Chronotropic Incompetence (inability of the heart to increase its rate appropriately in response to increased activity or metabolic need): 1 person, 100.00%
  8. Balance Disorder: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of sofosbuvir, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.